Do NSAIDs and Other Pain Relief Drugs Can Inhibit the Growth of Lactobacillaceae?

Hanna Kruszewska; Anna Zawistowska-Rojek; Stefan Tyski

doi:10.33073/pjm-2023-038

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) commonly used in clinical practice may cause gastrointestinal injuries and influence the gut microbiota. This study investigated the effects of various NSAIDs and some analgesics on the viability of Lactobacillaceae strains (including probiotic strains) in vitro. It was found that diclofenac, ibuprofen, ketoprofen, dexketoprofen, flurbiprofen, and acetylsalicylic acid inhibited the growth of lactobacilli at a concentration of 0.05−3.2 mg/ml. These MICs of NSAIDs are well above therapeutic plasma concentrations achieved in humans, indicating that the tested drugs should not inhibit the growth of lactobacilli in the human digestive tract.

References

Aronson JK. Meyler’s side effects of drugs (sixteenth edition). The international encyclopedia of adverse drug reactions and interactions. Dexketoprofen. Oxford (UK): Elsevier; 2016. p. 888–890. https://doi.org/10.1016/B978-0-444-53717-1.01685-1
Open DOI Search in Google Scholar Back to article
Bacchi S, Palumbo P, Sponta A, Coppolino MF. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Anti-inflamm Antiallergy Agents Med Chem. 2012;11(1):52–64. https://doi.org/10.2174/187152312803476255
Open DOI Search in Google Scholar Back to article
Bjarnason I, Scarpignato C, Holmgren E, Olszewski M, Rainsford KD, Lanas A. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology. 2018 Feb;154(3):500–514. https://doi.org/10.1053/j.gastro.2017.10.049
Open DOI Search in Google Scholar Back to article
Blaabjerg S, Artzi DM, Aabenhus R. Probiotics for the prevention of antibiotic-associated diarrhea in outpatients – A systematic review and meta-analysis. Antibiotics. 2017 Oct;6(4):21. https://doi.org/10.3390/antibiotics6040021
Open DOI Search in Google Scholar Back to article
Caillé G, Besner JG, Lacasse Y, Vézina M. Pharmacokinetic characteristics of ketoprofen suppositories. Biopharm Drug Dispos. 1980 Apr–Jun;1(4):195–201. https://doi.org/10.1002/bdd.2510010407
Open DOI Search in Google Scholar Back to article
Cheng X, Huang F, Zhang K, Yuan X, Song C. Effects of nonsteroidal anti-inflammatory and antibiotic drugs on the oral immune system and oral microbial composition in rats. Biochem Biophys Res Commun. 2018;507:420–425. https://doi.org/10.1016/j.bbrc.2018.11.054
Open DOI Search in Google Scholar Back to article
CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard – 10th ed. CLSI document M07-A10. Wayne (USA): Clinical and Laboratory Standards Institute; 2015.
Search in Google Scholar Back to article
Elshaer SL, Shaldam MA, Shaaban MI. Ketoprofen, piroxicam and indomethacin-suppressed quorum sensing and virulence factors in Acinetobacter baumannii. J Appl Microbiol. 2022 Oct; 133(4): 2182–2197. https://doi.org/10.1111/jam.15609
Open DOI Search in Google Scholar Back to article
EMA. Ipren, suppositories 125 mg [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2003 [cited 2023 Jun 30]. Available from http://art45-paediatric-studies-docs.ema.europa.eu/GROUP%20I/ibuprofen/ibuprofen%20573-CHC-9127-001.pdf
Search in Google Scholar Back to article
Endo H, Higurashi T, Hosono K, Sakai E, Sekino Y, Iida H, Sakamoto Y, Koide T, Takahashi H, Yoneda M, et al. Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol. 2011 Jul;46(7):894–905. https://doi.org/10.1007/s00535-011-0410-1
Open DOI Search in Google Scholar Back to article
Gajdacs M, Spengler G. The role of drug repurposing in the development of novel antimicrobial drugs: non-antibiotic pharmacological agents as quorum sensing-inhibitors. Antibiotics. 2019;8(4):270. https://doi.org/10.3390/antibiotics8040270
Open DOI Search in Google Scholar Back to article
Gonzalez-Canudas J, Garcia-Aguirre LJ, Medina-Nolasco A, Ruiz-Olmedo MI, Reyes LJM, Zambrano-Tapia L, Romero-Antonio Y, Molina-Pérez A, Amador-Hernández AG. Bioequivalence evaluation of two oral formulations of dexketoprofen-trometamol (solution and tablets) in healthy subjects: Results from a randomized, single-blind, crossover study. Trends Med. 2019;19:1–5. https://doi.org/10.15761/TiM.1000176
Open DOI Search in Google Scholar Back to article
Janssen GM, Venema JF. Ibuprofen: Plasma concentrations in man. J Int Med Res. 1985;13(1):68–73. https://doi.org/10.1177/030006058501300110
Open DOI Search in Google Scholar Back to article
Jiménez-Serna A, Hernandez-Sánchez H. Effect of different antibiotics and non-steroidal anti-inflammatory drugs on the growth of Lactobacillus casei Shirota. Curr Microbiol. 2011 Mar;62(3): 1028–1033. https://doi.org/10.1007/s00284-010-9819-7
Open DOI Search in Google Scholar Back to article
Kerry GR, Patra JK, Gouda S, Park Y, Shin HS, Das G. Benefaction of probiotics for human health: A review. J Food Drug Anal. 2018 Jul;26(3):927–939. https://doi.org/10.1016/j.jfda.2018.01.002
Open DOI Search in Google Scholar Back to article
Klopper KB, Deane SM, Dicks LMT. Aciduric strains of Lactobacillus reuteri and Lactobacillus rhamnosus, isolated from human feces, have strong adhesion and aggregation properties. Probiotics Antimicrob Proteins. 2018 Mar;10(1):89–97. https://doi.org/10.1007/s12602-017-9307-5
Open DOI Search in Google Scholar Back to article
Kmiec N, Welnicka-Jaskiewicz M, Jassem J. [Nonsteroidal anti-inflammatory drugs in the prevention and treatment of colorectal cancer] (in Polish). J Oncol. 2014;64(2):175–179. https://doi.org/10.5603/NJO.2014.0024
Open DOI Search in Google Scholar Back to article
Kruszewska H, Zareba T, Kociszewska A, Tyski S. Activity of selected non-antibiotic medicinal preparations against standard microorganisms including bacterial probiotic strains. Acta Pol Pharm Drug Res. 2021;78(2):179–185. https://doi.org/10.32383/appdr/136439
Open DOI Search in Google Scholar Back to article
Kruszewska H, Zaruba T, Tyski S. Examination of antimicrobial activity of selected non-antibiotic medicinal preparations. Acta Pol Pharm Drug Res. 2012;69(6):1368–1371.
Search in Google Scholar Back to article
Lagadinou M, Onisor MO, Rigas A, Musetescu DV, Gkentzi D, Assimakopoulos SF, Panos G, Marangos M. Antimicrobial properties on non-antibiotic drugs in the era of increased bacterial resistance. Antibiotics. 2020 Mar;9(3):107. https://doi.org/10.3390/antibiotics9030107
Open DOI Search in Google Scholar Back to article
Laudy AE, Kulinska E, Tyski S. The impact of efflux pump inhibitors on the activity of selected non-antibiotic medicinal products against Gram-negative bacteria. Molecules. 2017 Jan;22(1):114. https://doi.org/10.3390/molecules22010114
Open DOI Search in Google Scholar Back to article
Laudy AE, Mrowka A, Krajewska J, Tyski S. The influence of efflux pump inhibitors on the activity of non-antibiotics NSAIDS against Gram-negative rods. PLoS One. 2016 Jan;11(1):e0147131. https://doi.org/10.1371/journal.pone.0147131
Open DOI Search in Google Scholar Back to article
Laudy AE. Non-antibiotics, efflux pumps and drug resistance of Gram-negative rods. Pol J Microbiol. 2018 Jun;67(2):129–135. https://doi.org/10.21307/pjm-2018-017
Open DOI Search in Google Scholar Back to article
Lázár B, László SB, Hutka B, Toth AS, Mohammadzadeh A, Berekmeri E, Ägg B, Balogh M, Sajtos V, Kiraly K, et al. A comprehensive time course and correlation analysis of indomethacin-induced inflammation, bile acid alterations and dysbiosis in the rat small intestine. Biochem Pharmacol. 2021 Aug;190:114590. https://doi.org/10.1016/j.bcp.2021.114590
Open DOI Search in Google Scholar Back to article
Leäo C, Borges A, Simões M. NSAIDs as a drug repurposing strategy for biofilm control. Antibiotics. 2020 Sep;9(9):591. https://doi.org/10.3390/antibiotics9090591
Open DOI Search in Google Scholar Back to article
Liang X, Bittinger K, Li X, Abernethy DR, Bushman FD, Fitz Gerald GA. Bidirectional interactions between indomethacin and the murine intestinal microbiota. elife. 2015 Dec;4:e08973. https://doi.org/10.7554/eLife.08973
Open DOI Search in Google Scholar Back to article
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018 Mar 29;555(7698):623–628. https://doi.org/10.1038/nature25979
Open DOI Search in Google Scholar Back to article
Markowiak-Kopec P, Slizewska K. The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients. 2020 Apr;12(4):1107. https://doi.org/10.3390/nu12041107
Open DOI Search in Google Scholar Back to article
Maseda D, Ricciotti E. NSAID-gut microbiota interactions. Front Pharmacol. 2020 Aug;11:1153. https://doi.org/10.3389/fphar.2020.01153
Open DOI Search in Google Scholar Back to article
Montrose DC, Zhou XK, McNally EM, Sue E, Yantiss RK, Gross SS, Leve ND, Karoly ED, Suen CS, Ling L, et al. Celecoxib alters the intestinal microbiota and metabolome in association with reducing polyp burden. Cancer Prev Res (Phila). 2016 Sep;9(9):721–731. https://doi.org/10.1158/1940-6207.CAPR-16-0095
Open DOI Search in Google Scholar Back to article
Nadatani Y, Watanabe T, Suda W, Nakata A, Matsumoto Y, Kosaka S, Higashimori A, Otani K, Hosomi S, Tanakaet F, et al. Gastric acid inhibitor aggravates indomethacin-induced small intestinal injury via reducing Lactobacillus johnsonii. Sci Rep. 2019 Nov; 9(1):17490. https://doi.org/10.1038/s41598-019-53559-7
Open DOI Search in Google Scholar Back to article
Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T. Pharmacokinetics and pharmacodynamicsof acetylsalicylic acid after intravenous and oral administration to healthy volunteers. Clin Pharmacol. 2014 Mar;6:51–59. https://doi.org/10.2147/CPAA.S47895
Open DOI Search in Google Scholar Back to article
Nair BM, Cheung KJ Jr, Griffith A, Burns JL. Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest. 2004 Feb;113(3):464–473. https://doi.org/10.1172/JCI19710
Open DOI Search in Google Scholar Back to article
Novartis Pharmaceuticals UK Ltd. Voltarol 12.5 mg Suppositories summary of product characteristics [Internet]. Electronic Medicines Compendium; 2023 [cited 2023 Jun 30]. Available from https://www.medicines.org.uk/emc/product/1044/smpc
Search in Google Scholar Back to article
Phillips WJ, Currier BL. Analgesic pharmacology: II. Specific analgesics. J Am Acad Orthop Surg. 2004 Jul-Aug;12(4):221–233. https://doi.org/10.5435/00124635-200407000-00003
Open DOI Search in Google Scholar Back to article
Roda A, Sabatini L, Mirasoli M, Baraldini M, Roda E. Bioavailability of a new ketoprofen formulation for once-daily oral administration. Int J Pharm. 2002 Jul;241(1):165–172. https://doi.org/10.1016/s0378-5173(02)00230-2
Open DOI Search in Google Scholar Back to article
Sarzi-Puttini P, Atzeni F, Lanata L, Bagnasco M. Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis. Clin Exp Rheumatol. 2013 Sep–Oct; 31(5):731–738.
Search in Google Scholar Back to article
Scaroni C, Mazzoni PL, D’Amico E, Benvenuti C, Hind ID. Pharmacokinetics of oral and rectal flurbiprofen in children. Eur J Clin Pharmacol. 1984;27(3):367–369. https://doi.org/10.1007/BF00542178 Standards Institute; 2015.
Open DOI Search in Google Scholar Back to article
Suzuki T, Masui A, Nakamura J, Shiozawa H, Aoki J, Nakae H, Tsuda S, Imai J, Hideki O, Matsushima M, et al. Yogurt containing Lactobacillus gasseri mitigates aspirin-induced small bowel injuries: A prospective, randomized, double-blind, placebo-controlled trial. Digestion. 2017;95(1):49–54. https://doi.org/10.1159/000452361
Open DOI Search in Google Scholar Back to article
Syer SD, Blackler RW, Martin R, de Palma G, Rossi L, Verdu E, Bercik P, Surette MG, Aucouturier A, Langella P, et al. NSAID enteropathy and bacteria: A complicated relationship. J Gastroenterol. 2015 Apr;50(4):387–393. https://doi.org/10.1007/s00535-014-1032-1
Open DOI Search in Google Scholar Back to article
Tyski S. Non-antibiotics – drugs with additional antimicrobial activity. Acta Pol Pharm Drug Res. 2003;60(5):401–404.
Search in Google Scholar Back to article
Valentovic M. Flurbiprofen. In: Enna SJ and Bylun DB, editors. xPharm: The comprehensive pharmacology reference. New York (USA): Elsevier; 2007. p. 1–6. https://doi.org/10.1016/B978-008055232-3.61777-5
Open DOI Search in Google Scholar Back to article
Wang X, Tang Q, Hou H, Zhang W, Li M, Chen D, Gu Y, Wang B, Hou J, Liu Y, et al. Gut microbiota in NSAID enteropathy: New insights from inside. Front Cell Infect Microbiol. 2021 Jul;11:679396. https://doi.org/10.3389/fcimb.2021.679396
Open DOI Search in Google Scholar Back to article
Watanabe T, Nishio H, Tanigawa T, Yamagami H, Okazaki H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Asahara T, et al. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid. Am J Physiol Gastrointest Liver Physiol. 2009 Sep;297(3):G506-G513. https://doi.org/10.1152/ajpgi.90553.2008
Open DOI Search in Google Scholar Back to article
Willis JV, Kendall MJ, Flinn RM, Thornhill DP, Welling PG. The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur J Clin Pharmacol. 1979;16(6):405–410. https://doi.org/10.1007/BF00568201
Open DOI Search in Google Scholar Back to article
Yilmaz B, Erdem AF. Determination of flurbiprofen in human plasma by high-performance liquid chromatography. J Chromatogr Sci. 2015 Oct;53(9):1443–1448. https://doi.org/10.1093/chromsci/bmv032
Open DOI Search in Google Scholar Back to article
Yu T, Lao X, Zheng H. Influencing COX-2 activity by COX related pathways in inflammation and cancer. Mini Rev Med Chem. 2016; 16(15):1230–1243. https://doi.org/10.2174/1389557516666160505115743
Open DOI Search in Google Scholar Back to article
Zádori ZS, Kiraly K, Al-Khrasani M, Gyires K. Interactions between NSAIDs, opioids and the gut microbiota – Future perspectives in the management of inflammation and pain. Pharmacol Ther. 2023 Jan;241:108327. https://doi.org/10.1016/j.pharmthera.2022.108327
Open DOI Search in Google Scholar Back to article
Zawistowska-Rojek A, Tyski S. How to improve health with biological agents – Narrative review. Nutrients. 2022 Apr;14(9):1700. https://doi.org/10.3390/nu14091700
Open DOI Search in Google Scholar Back to article
Zimmermann P, Curtis N. Antimicrobial effects of antipyretics. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02268-16. https://doi.org/10.1128/AAC.02268-16
Open DOI Search in Google Scholar Back to article

Do NSAIDs and Other Pain Relief Drugs Can Inhibit the Growth of Lactobacillaceae?

Abstract

Paradigm

My account